Skip to content
Est. 1998 proudly celebrating 27 years of standing behind American companies
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

Autonomix Medical, Inc. (AMIX)

$4.45 -9.55% NASDAQ: AMIX · 15-min delayed
  • THE WOODLANDS, Texas
  • Public · NASDAQ: AMIX
  • 11 employees
$4.7MMarket cap
$0Revenue · FY2026
-$16.7MNet income
11Employees
AMIXNASDAQ
2024IPO

About Autonomix Medical, Inc.

Autonomix Medical Inc is a development-stage medical device company focused on advancing technologies for sensing and treating disorders of the nervous system. Its platform is designed to integrate high-sensitivity neural signal detection with targeted radiofrequency (RF) ablation, enabling a sense, treat, verify approach for nerve-targeted therapies. The Company operates in one reportable segment, which is advancing the development of technologies for sensing and treating disorders relating to the nervous system. It is initially focused on developing the technology for patients with pancreatic cancer and believes the technology has the potential to address several indications, including chronic pain management, hypertension, cardiovascular disease, and other nerve-related disorders.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Reported figures

Financial summary

Revenue FY2026
$0
Net income
-$16.7M
Total assets
$7.6M
Market cap
$4.7M

Source: SEC EDGAR · updated Jun 7, 2026

Multi-year

Revenue & profit trend

Revenue Net income
FY 2026

Financial statements

Income statement

Revenue
$0
Operating expenses
$17.0M
Operating income
-$17.0M
Income tax
$0
Net income
-$16.7M
EPS (basic)
$-2.32

Balance sheet

Total assets
$7.6M
Current assets
$7.6M
Total liabilities
$1.7M
Current liabilities
$1.7M
Shareholders’ equity
$5.9M

Cash flow

Operating cash flow
-$12.3M
Investing cash flow
-$10.0K
Financing cash flow
$10.2M
Net cash flow
-$2.1M

Statements via Polygon.io (SEC filings)

NASDAQ: AMIX
$4.45 -9.55%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$4.45 $42.21

52-week range

Market cap
$4.7M
Shares outstanding
1.1M
Open
Day range
Prev close
Volume
IPO date
Jan 29, 2024

Autonomix Medical, Inc. (AMIX) Stock Price

  • Reported a net loss of $16.7M in FY2026.
  • Trading 89% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review Autonomix Medical, Inc..

Write a review
Newsroom

News about Autonomix Medical, Inc.

News & sentiment via Polygon.io

FAQ

Autonomix Medical, Inc.: frequently asked questions

Is Autonomix Medical, Inc. an American company?

Autonomix Medical, Inc. is a US-based company headquartered in The Woodlands, Texas, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is Autonomix Medical, Inc. headquartered?

Autonomix Medical, Inc. is headquartered in The Woodlands, Texas, United States.

Is Autonomix Medical, Inc. publicly traded?

Yes — Autonomix Medical, Inc. is a publicly traded company. Its stock trades under the ticker symbol AMIX on the NASDAQ.

What does Autonomix Medical, Inc. do?

Autonomix Medical, Inc. is an American Medical Devices company in the Health & Beauty sector.

Explore

Similar companies

Browse all →